Daily Newsletter

14 September 2023

Daily Newsletter

14 September 2023

Walgreens and Pearl Health to expedite value-based care expansion

Technology and insight solutions offered by Pearl Health enable clinical teams to provide personalised treatments that are required for quality-focused care.

September 13 2023

Walgreens Boots Alliance’s division Walgreens and Pearl Health have entered into a strategic alliance to expedite value-based care expansion, in partnership with community-based primary care physicians.

Technology and insight solutions offered by Pearl Health enable clinical teams to provide personalised treatments that are required for quality-focused care.

The collaboration with Pearl Health allows Walgreens to gain access to an additional complementary value-based delivery channel.

Walgreens Boots Alliance US Healthcare executive vice-president and president John Driscoll said: “Walgreens is committed to being the partner of choice for providers and health systems looking to transition quickly and effectively to value-based care and improve outcomes in the communities they serve.

“Our partnership with Pearl Health allows us to reach more communities faster and enable comprehensive, affordable care that improves long-term health outcomes and fosters healthier communities.”

Walgreens will offer complementary services, including immunisations, medication adherence, care gap closure, diagnostic testing, and prescription fulfilment.

Working with providers, it will also help patients discharg and transition from the hospital to home.

Pearl Health CEO Michael Kopko said: “Our technology-powered value-based care model aligns seamlessly with the healthcare services Walgreens offers, particularly in the most vulnerable communities.

“With a focus on proactive, coordinated care, we’ll collaborate to deliver a better solution to providers and ultimately deliver high-quality services to patients while managing their care efficiently.

“We’re very excited about the implications of this partnership for patients in Medicare and beyond.”

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Primarily due to COVID-19, the healthcare sector has witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close